Philip L. Smith

Philip L. Smith

Director/Board Member at REDPOINT BIO CORPORATION
76 year
Health Technology
Finance
Consumer Services

Profile

Philip L.
Smith
is currently a Director at Linguagen Corp., Trinity Biosystems, Inc., and Mid-Atlantic Capital Alliance.
Previously, he held positions as a Director at Robcor Properties, Inc., GlaxoSmithKline Pharmaceuticals Ltd., Dr. Reddy's Research & Development BV, Avantium Technologies BV, Onyvax Ltd., and GSK Equity Investments Ltd. He has also pursued his education, earning graduate and doctorate degrees from Northeastern University and an undergraduate degree from the University of Maine.

Philip L. Smith active positions

CompaniesPositionStart
REDPOINT BIO CORPORATION Director/Board Member -
Mid-Atlantic Capital Alliance
Director/Board Member -

Former positions of Philip L. Smith

CompaniesPositionEnd
Director/Board Member 11/05/2010
Private Equity Investor 30/01/2009
Director/Board Member 04/07/2007
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED Corporate Officer/Principal 31/05/2002
Director/Board Member -
See the detail of Philip L. Smith's experience

Training of Philip L. Smith

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

42

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Finance

Finance

Health Technology

Health Technology

Process Industries

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Health Technology

Mid-Atlantic Capital Alliance

  1. Stock Market
  2. Insiders
  3. Philip L. Smith
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!